Literature DB >> 3001353

Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded.

R Hamelin, K Kabat, D Blair, R B Arlinghaus.   

Abstract

ts110 Moloney murine sarcoma virus (Mo-MuSV)-nonproductively infected cells (6m2) have a transformed phenotype at 28 to 33 degrees C and a normal phenotype at 39 degrees C. At temperatures permissive for transformation, 6m2 cells contain P58gag produced from the 4.0-kilobase (kb) viral RNA genome and P85gag-mos translated from a 3.5-kb spliced mRNA. At 39 degrees C, only the 4.0-kb RNA and its product P58gag are detected. Two temperature-sensitive defects have been observed in ts110-infected 6m2 cells: (i) the splicing of the 4.0-kb RNA to the 3.5-kb RNA; and (ii) the thermolability of P85gag-mos and its kinase activity relative to the wild-type revertant protein, termed P100gag-mos (R.B. Arlinghaus, J. Gen. Virol. 66:1845-1853, 1985). In the present study, we examined the mos gene products of two cell lines (204-2F6 and 204-2F8) obtained by infection of normal rat kidney cells with ts110 Mo-MuSV as a simian sarcoma-associated virus pseudotype to see whether the temperature-sensitive splicing defect could be transferred by viral infection. Southern blot analysis of these two cell lines showed that viral DNAs containing restriction fragments from cellular DNA are different from those in 6m2 cells, indicating that 204-2F6 and 204-2F8 cells have different ts110 provirus integration sites from those of 6m2 cells. Northern blots, S1 mapping analyses, and immunoprecipitation experiments showed unequivocally that the splicing defect of ts110 Mo-MuSV is virus encoded and is independent of host cell factors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001353      PMCID: PMC252727     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

Authors:  L J Arcement; W L Karshin; R B Naso; G Jamjoom; R B Arlinghaus
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells.

Authors:  S A Aaronson; S P Rowe
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

5.  Effects of actinomycin D, toyocamycin and cycloheximide on the synthesis of low-molecular-weight nuclear RNAs in HeLa cells.

Authors:  R Hamelin; C J Larsen; A Tavitian
Journal:  Eur J Biochem       Date:  1973-06

6.  Biosynthesis of Rauscher leukemia viral proteins.

Authors:  R B Naso; L J Arcement; R B Arlinghaus
Journal:  Cell       Date:  1975-01       Impact factor: 41.582

7.  Evolutionary relationships between gag gene-coded proteins of murine and primate endogenous type C RNA viruses.

Authors:  M Barbacid; J R Stephenson; S A Aaronson
Journal:  Cell       Date:  1977-04       Impact factor: 41.582

8.  Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

9.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

View more
  7 in total

1.  Regulation of RNA splicing in gag-deficient mutants of Moloney murine sarcoma virus MuSVts110.

Authors:  M De Mars; D A Sterner; S M Chiocca; N W Biggart; E C Murphy
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA.

Authors:  R Hamelin; N Honore; D Sergiescu; B Singh; J Gerfaux; R B Arlinghaus
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Exploitation of a thermosensitive splicing event to study pre-mRNA splicing in vivo.

Authors:  P E Cizdziel; M de Mars; E C Murphy
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

4.  A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector.

Authors:  J Friel; C Stocking; A Stacey; W Ostertag
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells.

Authors:  M A Nash; M K Meyer; G L Decker; R B Arlinghaus
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Activation of thermosensitive RNA splicing and production of a heat-labile P85gag-mos kinase by the introduction of a specific deletion in murine sarcoma virus-124 DNA.

Authors:  M de Mars; P E Cizdziel; E C Murphy
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Moloney murine sarcoma virus MuSVts110 DNA: cloning, nucleotide sequence, and gene expression.

Authors:  L Huai; S M Chiocca; M A Gilbreth; J R Ainsworth; L A Bishop; E C Murphy
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.